For research use only. Not for therapeutic Use.
Zonisamide sodium(Cat No.:I004568)is a sodium salt form of zonisamide, a sulfonamide-based anticonvulsant used primarily in the management of epilepsy. It works by stabilizing neuronal membranes, reducing repetitive neuronal firing through inhibition of sodium and calcium channels, and modulating GABA-mediated neurotransmission. Zonisamide sodium has shown efficacy in treating partial-onset seizures and is being explored for neuroprotective potential in neurodegenerative conditions like Parkinson’s disease. Its multi-targeted action makes it a valuable tool in neurological research, particularly in studies focused on seizure control and neuroprotection strategies.
Catalog Number | I004568 |
CAS Number | 68291-98-5 |
Synonyms | sodium;1,2-benzoxazol-3-ylmethylsulfonylazanide |
Molecular Formula | C8H7N2NaO3S |
Purity | ≥95% |
Target | Calcium Channel |
Solubility | DMSO 42 mg/mL; Water <1 mg/mL |
Storage | Store at -20C |
IUPAC Name | sodium;1,2-benzoxazol-3-ylmethylsulfonylazanide |
InChI | InChI=1S/C8H7N2O3S.Na/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7;/h1-4H,5H2,(H-,9,11,12);/q-1;+1 |
InChIKey | ZVBIRPKGWOVBLG-UHFFFAOYSA-N |
SMILES | C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)[NH-].[Na+] |
Reference | <p style=/line-height:25px/> |